Patents by Inventor Vincent A. Miller
Vincent A. Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250195514Abstract: Methods and compositions for treating cholangiocarcinoma.Type: ApplicationFiled: December 16, 2024Publication date: June 19, 2025Applicant: Foundation Medicine, Inc.Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
-
Publication number: 20250146077Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: ApplicationFiled: September 9, 2024Publication date: May 8, 2025Applicant: Foundation Medicine, Inc.Inventors: Maureen T. CRONIN, Garrett Michael FRAMPTON, Doron LIPSON, Vincent A. MILLER, Gary PALMER, Jeffrey S. ROSS, Philip James STEPHENS, Roman YELENSKY
-
Patent number: 12274699Abstract: Methods and compositions for treating cholangiocarcinoma.Type: GrantFiled: June 30, 2023Date of Patent: April 15, 2025Assignee: Foundation Medicine, Inc.Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
-
Publication number: 20250104879Abstract: Provided are systems and methods for capturing outcome information associated with various cancer treatments. The system facilitates capture and analysis of cancer treatment information and associated outcome information. The treatment and outcome information can include genomic analysis and information on treatment of different cancers. The system can store and analyze any one or more of: tumor type, genomic alterations (e.g., genes and associated alterations, gene sequence mutations, alterations, amplifications, deletions, etc.), and treatment data (including, for example, treatments targeted to specific genes and/or genomic alterations). Users of the outcome system can supply and use the treatment and outcome information to facilitate diagnosis and therapy decisions. User interfaces within the system can be configured to allow users to easily locate outcome information associated with particular treatments of tumors having certain genomic alterations.Type: ApplicationFiled: August 14, 2024Publication date: March 27, 2025Applicant: Foundation Medicine, Inc.Inventors: Michael PELLINI, Gary PALMER, Mary Patricia LANCELOTTA, Matthew J. HAWRYLUK, Vincent A. MILLER
-
Publication number: 20240392378Abstract: Methods and compositions for treating cancer such as melanomas are disclosed.Type: ApplicationFiled: June 22, 2023Publication date: November 28, 2024Applicants: Foundation Medicine, Inc., Vanderbilt UniversityInventors: Garrett Michael FRAMPTON, Roman YELENSKY, James Xin SUN, Douglas Buckner JOHNSON, Christine Marie LOVLY, Jeffrey Alan SOSMAN, David FABRIZIO, Philip James STEPHENS, Vincent A. MILLER
-
Patent number: 12116638Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: GrantFiled: February 16, 2022Date of Patent: October 15, 2024Assignee: Foundation Medicine, Inc.Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
-
Patent number: 12087453Abstract: Provided are systems and methods for capturing outcome information associated with various cancer treatments. The system facilitates capture and analysis of cancer treatment information and associated outcome information. The treatment and outcome information can include genomic analysis and information on treatment of different cancers. The system can store and analyze any one or more of: tumor type, genomic alterations (e.g., genes and associated alterations, gene sequence mutations, alterations, amplifications, deletions, etc.), and treatment data (including, for example, treatments targeted to specific genes and/or genomic alterations). Users of the outcome system can supply and use the treatment and outcome information to facilitate diagnosis and therapy decisions. User interfaces within the system can be configured to allow users to easily locate outcome information associated with particular treatments of tumors having certain genomic alterations.Type: GrantFiled: August 10, 2022Date of Patent: September 10, 2024Assignee: Foundation Medicine, Inc.Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
-
Publication number: 20230372338Abstract: Methods and compositions for treating cholangiocarcinoma.Type: ApplicationFiled: June 30, 2023Publication date: November 23, 2023Applicant: Foundation Medicine, Inc.Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
-
Patent number: 11771698Abstract: Methods and compositions for treating cholangiocarcinoma.Type: GrantFiled: March 17, 2021Date of Patent: October 3, 2023Assignee: Foundation Medicine, Inc.Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
-
Patent number: 11725247Abstract: Methods and compositions for treating cancer such as melanomas are disclosed.Type: GrantFiled: February 27, 2017Date of Patent: August 15, 2023Assignees: FOUNDATION MEDICINE, INC., VANDERBILT UNIVERSITYInventors: Garrett Michael Frampton, Roman Yelensky, James Xin Sun, Douglas Buckner Johnson, Christine Marie Lovly, Jeffrey Alan Sosman, David Fabrizio, Philip James Stephens, Vincent A. Miller
-
Patent number: 11578372Abstract: Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.Type: GrantFiled: November 14, 2019Date of Patent: February 14, 2023Assignee: Foundation Medicine, Inc.Inventors: Matthew J. Hawryluk, Doron Lipson, Vincent A. Miller, Philip James Stephens
-
Publication number: 20220399131Abstract: Provided are systems and methods for capturing outcome information associated with various cancer treatments. The system facilitates capture and analysis of cancer treatment information and associated outcome information. The treatment and outcome information can include genomic analysis and information on treatment of different cancers. The system can store and analyze any one or more of: tumor type, genomic alterations (e.g., genes and associated alterations, gene sequence mutations, alterations, amplifications, deletions, etc.), and treatment data (including, for example, treatments targeted to specific genes and/or genomic alterations). Users of the outcome system can supply and use the treatment and outcome information to facilitate diagnosis and therapy decisions. User interfaces within the system can be configured to allow users to easily locate outcome information associated with particular treatments of tumors having certain genomic alterations.Type: ApplicationFiled: August 10, 2022Publication date: December 15, 2022Applicant: Foundation Medicine, Inc.Inventors: Michael PELLINI, Gary PALMER, Mary Patricia LANCELOTTA, Matthew J. HAWRYLUK, Vincent A. MILLER
-
Patent number: 11450438Abstract: A system for tracking and analyzing cancer treatment and outcome information includes a user interface (UI) component for allowing selection of an alteration, an affected gene, an affected pathway, a tumor type, and/or a treatment; a processor configured to receive treatment information and outcome information associated with a patient population; organize the treatment information and the outcome information into at least one tuple; and generate outcome summary information; and an analysis component configured to compare a current patient record for a current patient to existing treatment information for the patient population, identify similar patients in the patient population based on information in the current patient record, and filter a grouping of similar patients; the processor is further configured to display, on the UI component, the outcome summary information; enable navigation within the treatment and outcome information; and identify, based on the outcome information, an appropriate treatment fType: GrantFiled: September 23, 2019Date of Patent: September 20, 2022Assignee: Foundation Medicine, Inc.Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
-
Publication number: 20220251667Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: ApplicationFiled: February 16, 2022Publication date: August 11, 2022Applicant: Foundation Medicine, Inc.Inventors: Maureen T. CRONIN, Garrett Michael FRAMPTON, Doron LIPSON, Vincent A. MILLER, Gary PALMER, Jeffrey S. ROSS, Philip James STEPHENS, Roman YELENSKY
-
Patent number: 11286532Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: GrantFiled: January 22, 2018Date of Patent: March 29, 2022Assignee: FOUNDATION MEDICINE, INC.Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
-
Publication number: 20210283134Abstract: Methods and compositions for treating cholangiocarcinoma.Type: ApplicationFiled: March 17, 2021Publication date: September 16, 2021Applicant: Foundation Medicine, Inc.Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
-
Patent number: 10980804Abstract: Methods and compositions for treating cholangiocarcinoma.Type: GrantFiled: January 17, 2014Date of Patent: April 20, 2021Assignee: FOUNDATION MEDICINE, INC.Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
-
Publication number: 20200299775Abstract: Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.Type: ApplicationFiled: November 14, 2019Publication date: September 24, 2020Inventors: Matthew J. Hawryluk, Doron Lipson, Vincent A. Miller, Philip James Stephens
-
Publication number: 20200211679Abstract: A system for tracking and analyzing cancer treatment and outcome information includes a user interface (UI) component for allowing selection of an alteration, an affected gene, an affected pathway, a tumor type, and/or a treatment; a processor configured to receive treatment information and outcome information associated with a patient population; organize the treatment information and the outcome information into at least one tuple; and generate outcome summary information; and an analysis component configured to compare a current patient record for a current patient to existing treatment information for the patient population, identify similar patients in the patient population based on information in the current patient record, and filter a grouping of similar patients; the processor is further configured to display, on the UI component, the outcome summary information; enable navigation within the treatment and outcome information; and identify, based on the outcome information, an appropriate treatment fType: ApplicationFiled: September 23, 2019Publication date: July 2, 2020Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
-
Publication number: 20190233897Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: ApplicationFiled: September 5, 2018Publication date: August 1, 2019Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
